196 related articles for article (PubMed ID: 33049234)
1. Contemporary Trends in Presentation and Management of Spermatocytic Seminoma.
Patel PM; Patel HD; Koehne EL; Doshi C; Belshoff A; Seffren CM; Baker M; Gorbonos A; Gupta G
Urology; 2020 Dec; 146():177-182. PubMed ID: 33049234
[TBL] [Abstract][Full Text] [Related]
2. Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis.
Stokes W; Amini A; Maroni PD; Kessler ER; Stokes C; Cost CR; Greffe BS; Garrington TP; Liu AK; Cost NG
J Pediatr Urol; 2017 Aug; 13(4):386.e1-386.e7. PubMed ID: 28153774
[TBL] [Abstract][Full Text] [Related]
3. Temporal trends in management and outcomes of testicular cancer: A population-based study.
Leveridge MJ; Siemens DR; Brennan K; Izard JP; Karim S; An H; Mackillop WJ; Booth CM
Cancer; 2018 Jul; 124(13):2724-2732. PubMed ID: 29660851
[TBL] [Abstract][Full Text] [Related]
4. When is a Seminoma not a Seminoma? The Incidence, Risk Factors and Management of Patients With Testicular Seminoma With Discordant Elevated Serum Alpha-fetoprotein.
Fero KE; Lec PM; Sharma V; Lenis AT; Low J; Litwin MS; Leapman MS; Chamie K
Urology; 2021 Nov; 157():188-196. PubMed ID: 34389428
[TBL] [Abstract][Full Text] [Related]
5. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
[TBL] [Abstract][Full Text] [Related]
6. Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012.
Paly JJ; Lin CC; Gray PJ; Hallemeier CL; Beard C; Sineshaw H; Jemal A; Efstathiou JA
Pract Radiat Oncol; 2016; 6(6):e249-e258. PubMed ID: 27345128
[TBL] [Abstract][Full Text] [Related]
7. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
Oldenburg J; Aparicio J; Beyer J; Cohn-Cedermark G; Cullen M; Gilligan T; De Giorgi U; De Santis M; de Wit R; Fosså SD; Germà-Lluch JR; Gillessen S; Haugnes HS; Honecker F; Horwich A; Lorch A; Ondruš D; Rosti G; Stephenson AJ; Tandstad T
Ann Oncol; 2015 May; 26(5):833-838. PubMed ID: 25378299
[TBL] [Abstract][Full Text] [Related]
8. Treatment of a population based sample of men diagnosed with testicular cancer in the United States.
Osswald M; Harlan LC; Penson D; Stevens JL; Clegg LX
Urol Oncol; 2009; 27(6):604-10. PubMed ID: 18799329
[TBL] [Abstract][Full Text] [Related]
9. Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy.
Mazzone E; Mistretta FA; Knipper S; Tian Z; Palumbo C; Gandaglia G; Soulieres D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Clin Genitourin Cancer; 2019 Dec; 17(6):e1153-e1162. PubMed ID: 31515197
[TBL] [Abstract][Full Text] [Related]
10. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
11. [Surveillance of stage I testicular seminoma: 20 years oncological results].
Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
[TBL] [Abstract][Full Text] [Related]
12. Management of testicular seminoma.
Milosevic MF; Gospodarowicz M; Warde P
Semin Surg Oncol; 1999 Dec; 17(4):240-9. PubMed ID: 10588852
[TBL] [Abstract][Full Text] [Related]
13. Management of testicular seminoma. Our experience.
Sperlongano P; Pisaniello D; Di Mauro U; Pone D; Casoli E
Ann Ital Chir; 2000; 71(1):127-30. PubMed ID: 10829535
[TBL] [Abstract][Full Text] [Related]
14. Current controversies on the role of retroperitoneal lymphadenectomy for testicular cancer.
Mano R; Di Natale R; Sheinfeld J
Urol Oncol; 2019 Mar; 37(3):209-218. PubMed ID: 30446455
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for loss to follow-up during active surveillance of patients with Stage I seminoma.
Endo T; Kawai K; Kamba T; Inai H; Uchida K; Miyazaki J; Kamoto T; Ogawa O; Nishiyama H
Jpn J Clin Oncol; 2014 Apr; 44(4):355-9. PubMed ID: 24558127
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant radiotherapy for Stage I seminoma: A Single-institutional experience.
Kanyilmaz G; Saricanbaz I; Bora H; Karahacioglu E; Erkal EY
J Cancer Res Ther; 2019 Mar; 15(Supplement):S87-S90. PubMed ID: 30900627
[TBL] [Abstract][Full Text] [Related]
17. Changes in adjuvant therapy utilization in stage I seminoma: are they enough to prevent overtreatment?
Kohut RM; Minnillo BJ; Kypriotakis G; Abouassaly R; Zhu H
Urology; 2014 Dec; 84(6):1319-24. PubMed ID: 25432823
[TBL] [Abstract][Full Text] [Related]
18. Surveillance and Radiation Therapy for Stage I Seminoma--Have We Learned From the Evidence?
Glaser SM; Vargo JA; Balasubramani GK; Beriwal S
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):75-84. PubMed ID: 26700704
[TBL] [Abstract][Full Text] [Related]
19. Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility.
Cooper DE; L'esperance JO; Christman MS; Auge BK
J Urol; 2008 Aug; 180(2):577-81; discussion 581-2. PubMed ID: 18554661
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
Kawai T; Tanaka Y;
Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
